CVS Health Ventures

What CVS Health Ventures does

CVS Health Ventures is the dedicated corporate venture capital investment platform of CVS Health (NYSE: CVS), established in 2021 and headquartered in Woonsocket, Rhode Island. The fund invests in early- and growth-stage healthcare technology startups through a multi-vehicle structure that includes limited partner commitments, a dedicated corporate venture fund, and minority growth equity positions, with cumulative deployed capital exceeding $1 billion across direct and LP investments. It manages a portfolio of more than 40 companies organized around four stated investment themes: Empower Tech-Enabled Workflow, Disruptive Technology, Simplifying Complexity in Health Care, and Consumer-Centric Health. Reported portfolio companies span generative AI ambient documentation (Abridge), healthcare AI data infrastructure (H1), autonomous medical coding (Fathom), AI payment integrity (Codoxo), digital mental health therapeutics (Big Health), obesity and metabolic care (Knownwell), kidney care (Strive Health), value-based Medicaid (Waymark, Main Street Health), behavioral health (Array, Wayspring, Workit, Nema), autism care (Cortica), neurodegenerative disease (Synapticure), oncology value-based care (Thyme Care), and healthcare fintech (Lynx).

CVS Health Ventures does not charge portfolio companies for capital; its economics derive from equity ownership and CVS Health's strategic value-creation. The fund's primary value proposition is connecting portfolio companies with CVS Health's enterprise capabilities — pharmacy distribution, retail footprint, Aetna and Caremark payer assets, MinuteClinic clinical operations, and regulatory know-how — and over 70% of portfolio companies have established a business relationship with CVS Health, indicating that the platform is operationally integrated with the parent rather than purely financial. Recent examples include Aetna's collaboration with Oshi Health on virtual digestive care and a co-built AI model with H1 to improve provider directory accuracy.

Go-to-market is enterprise relationship-driven: deal sourcing combines direct outreach, healthcare conferences (HLTH, MedCity News Bullseye), CV-platform referrals, and inbound from the corporate parent's business units. Lead positions are taken selectively in rounds that align with strategic priorities (e.g., Codoxo Series C $35M, H1 $40M, Knownwell $25M, Cortica Series D extension $40M), while the fund participates in larger rounds led by specialist VCs and growth investors (Oshi $60M Series C, Strive $166M Series C, Abridge $30M, Waymark $42M). The team of approximately 17 investment professionals is led by Managing Partner Vijay Patel with Partners Alex James and Justin Brock, and includes a dedicated market development function led by Executive Director and Partner Andrea Messina that drives integration between portfolio companies and CVS Health operating units.

Name

CVS Health Ventures

Legal name

CVS Health Ventures

Website

https://cvshealthventures.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

CVS Health Ventures is the dedicated corporate venture capital arm of CVS Health (NYSE: CVS), investing in early- and growth-stage healthcare technology startups across four themes: tech-enabled workflows, disruptive technology, healthcare complexity simplification, and consumer-centric health. The fund manages a portfolio of 40+ companies and over $1 billion in deployed capital.

Ownership category

akta.pro rank

Product category

Corporate Venture Capital

NAICS

Funds, Trusts, and Other Financial Vehicles (525)

SIC

Finance Services (6199)

akta.pro primary industry

Strategic / Balance-Sheet CVC (On-balance-sheet investing) (FSANAHAA)

akta.pro secondary industries

Captive CVC Fund (Dedicated corporate fund structure) (FSANAHAB), Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)

Keywords

• Corporate venture capital
• Healthcare technology investments
• Digital health startups
• Minority growth equity
• Venture capital platform

Headquarters

HQ city

Woonsocket

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Investment Returns: CVS Health Ventures generates returns through equity investments in healthcare technology startups. The fund seeks to realize returns through portfolio company exits, IPOs, and strategic acquisitions while creating enterprise value for CVS Health.
2. Strategic Business Development: The fund creates value by establishing business relationships between portfolio companies and CVS Health operations, with over 70% of portfolio companies having established business relationships with CVS Health.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

CVS Health Ventures is a corporate venture capital fund that makes minority equity investments, growth equity investments, and limited partner commitments in early-stage healthcare technology startups aligned with CVS Health's strategic priorities. The platform connects portfolio companies to CVS Health's enterprise capabilities—including retail pharmacy, the Aetna health plan, and care delivery operations—to accelerate scaling, with more than 70% of portfolio companies establishing business relationships with CVS Health operating units.

Product overview

CVS Health Ventures is a corporate venture capital investment platform established in 2021 that invests in high-potential healthcare startups. The firm manages a portfolio of 40+ companies aligned with CVS Health's strategic priorities across four investment themes: Empower Tech-Enabled Workflow, Disruptive Technology, Simplifying Complexity in Health Care, and Consumer-Centric Health. The portfolio spans diverse healthcare sectors including behavioral health (Array, Nema, Vita Health, Workit), chronic disease management (Knownwell, Strive Health, Monogram Health), digital therapeutics (Big Health, Oui Therapeutics), healthcare AI (Abridge, Ellipsis Health, H1, Codoxo, Fathom), care coordination (Kouper, Thyme Care), and specialty care (Cortica, Synapticure, Oshi Health). 70%+ of portfolio companies have established business relationships with CVS Health. CVS Health Ventures offers portfolio companies access to CVS Health's enterprise capabilities and consumer connections to help them scale faster.

Differentiator

Problem solved

Functional benefit

Products and services

• Direct Minority Equity Investments (Dedicated Corporate Venture Capital Fund) Minority equity investments made directly by CVS Health Ventures into early-stage healthcare technology startups, structured to align with the firm's four investment themes: Empower Tech-Enabled Workflow, Disruptive Technology, Simplifying Complexity in Health Care, and Consumer-Centric Health. Investments provide founders with capital plus access to CVS Health enterprise capabilities and consumer connections.
• Growth Equity Program Later-stage venture and growth equity investments in healthcare companies positioned to provide strategic value to CVS Health enterprise operations, led by Partner Justin Brock. Targets companies that need scaling capital and a corporate development partner.
• Limited Partner Investments in External Healthcare Venture Funds Commitments made by CVS Health Ventures as a limited partner into external healthcare-focused venture capital funds, providing CVS Health with broader deal flow visibility and co-investment capacity alongside external GPs.
• Market Development Function for Portfolio Companies Internal service within CVS Health Ventures that connects portfolio companies to CVS Health business units (pharmacy, Aetna, Oak Street Health, and other operating units) and helps startups navigate to the appropriate internal CVS Health teams, enabling pilots, partnerships, and commercial relationships.

Quantifiable outcome

• 70%+ of portfolio companies establish business relationships with CVS Health
• +3 more outcomes

Named customers32 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature3 records

Partnerships

Two partnerships are on record, tiered flagship and minor.

• CVS HealthflagshipStrategic or Co-development Partner · 1 January 2021CVS Health Ventures is the dedicated venture capital investment platform of CVS Health, established to drive healthcare innovation and digital disruption. The fund leverages CVS Health's national footprint, omnichannel digital presence, and enterprise capabilities to support portfolio companies.
• MedCity NewsminorGTM or Marketing PartnerCVS Health Ventures is a confirmed attendee and speaker at MedCity News' Bullseye invitation-only event focusing on healthcare investors and corporate business development leaders, particularly around AI in healthcare and cross-sector collaboration.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Optum Ventures: Optum Ventures is the corporate venture capital arm of UnitedHealth Group/Optum, investing in healthcare technology, digital health, and health services companies. It is the most direct comparable as the largest peer health-services CVC with similar thesis structure (direct investments plus portfolio-Optum integration).
• Kaiser Permanente Ventures: Kaiser Permanente Ventures invests on behalf of one of the largest US integrated payer-provider systems, with a similar thesis of strategic minority investments in emerging healthcare technologies that can be deployed across the parent system's scale.
• Mass General Brigham Innovation: Mass General Brigham Innovation invests strategic capital on behalf of a major academic health system - directly comparable as a health-system anchored CVC deploying capital into digital health and care delivery startups aligned with parent priorities.
• Echo Health Ventures: Echo Health Ventures is a strategic healthcare CVC backed by multiple payer and provider systems (including CVS Health Ventures' co-investor on Thyme Care). It pursues a comparable thesis of strategic minority investing in healthcare innovation with health-plan portfolio integration.
• Oak HC/FT: Oak HC/FT is a healthcare-focused venture capital firm that led Oshi Health's Series C where CVS Health Ventures participated. Both target growth-stage digital health and fintech-enabled care delivery companies, making it a directly comparable thesis peer.
• Town Hall Ventures: Town Hall Ventures is a healthcare-focused venture firm investing in companies serving vulnerable populations, payors, and providers with emphasis on value-based care - directly comparable thesis to CVS Health Ventures' Medicaid/rural care bets (Main Street Health, Waymark, Wayspring, Monogram Health).
• NewYork-Presbyterian Ventures: NewYork-Presbyterian Ventures is the CVC arm of one of the largest US academic health systems, investing across digital health, care delivery, and healthcare AI with the same health-system-anchored strategic model as CVS Health Ventures.

Broad incumbents

• GV (Google Ventures) Healthcare: GV is the venture arm of Alphabet with a dedicated healthcare practice investing in digital health and life sciences. Comparable as a large tech-anchored CVC with healthcare depth, though broader in scope than CVS Health Ventures' payer/provider-anchored thesis.
• Andreessen Horowitz Bio Health Fund: a16z Bio/Health is a large incumbent VC with deep healthcare and digital health portfolios (including companies like Abridge, leading ambient AI documentation in healthcare that competes with portfolio overlap). Overlap is partial rather than direct since a16z is financial-return led rather than corporate-anchored.
• General Catalyst (Healthcare): General Catalyst is a large multi-stage venture firm with a significant healthcare practice that has backed multiple digital health startups (and co-invested with CVS Health Ventures in H1). Comparable as a broad incumbent VC with deep healthcare exposure, though it is financial-return-led rather than strategically anchored.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cvs-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments41 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CVS Health Ventures